Catalyst Pharmaceuticals (CPRX) Free Cash Flow Growth (3y) (2013 - 2026)
Catalyst Pharmaceuticals (CPRX) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.07% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 70.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.60% |
| Dec 31, 2025 | 3.83% |
| Sep 30, 2025 | -7.74% |
| Jun 30, 2025 | 39.61% |
| Mar 31, 2025 | 92.04% |
| Dec 31, 2024 | 54.66% |
| Sep 30, 2024 | 49.71% |
| Jun 30, 2024 | 59.94% |
| Mar 31, 2024 | 121.92% |
| Dec 31, 2023 | 61.84% |
| Sep 30, 2023 | 57.88% |
| Jun 30, 2023 | 32.35% |
| Mar 31, 2023 | 18.48% |
| Dec 31, 2022 | 48.28% |
| Sep 30, 2022 | 36.43% |
| Jun 30, 2022 | 23.04% |
| Mar 31, 2022 | 45.13% |
| Dec 31, 2021 | 62.31% |
| Sep 30, 2021 | 72.15% |
| Jun 30, 2021 | 74.17% |